Reckitt Benckiser competitors

Mr. Farrell has been our Chief Executive Officer since January 2016. From November 2014 through December 2015 Mr. Farrell had been our Chief Financial Officer and Chief Operating Officer. From May 2007 through October 2014, Mr. Farrell had been our Executive Vice President and Chief Financial Officer, and from September 2006 through May 2007, he was our Vice President and Chief Financial Officer. Mr. Farrell was Executive Vice President and Chief Financial Officer of Alpharma Inc. from April 2002 through August 2006. From July 2000 through April 2002, he served as Vice President, Investor Relations & Communications at Ingersoll-Rand Ltd. From November 1994 through June 2000, he held various senior financial positions at AlliedSignal Inc. Mr. Farrell currently serves as a member of the board of directors of Lydall, Inc., a supplier of engineered thermal, acoustical and filtration products.

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Experienced C Suite General Manager with track record of consistently delivering exceptional results across multiple industries, in both public and private companies. Known for reinvigorating stagnant businesses or accelerating high growth businesses with category driving innovation, industry leading productivity, and smart p&l management. Multi functional experience. Creative problem solver. Paradigm buster. Entrepreneurial leader.

Philip 'Phil' Blake is an Head:US Region at Bayer Schering Pharma, President/CEO at Bayer, and Board Member at Nexia Biotechnologies. He has worked as Exec VP at Bayer, Senior VP at Bayer, and Head at Bayer HealthCare.